Thursday, we saw shares of the developmental biopharmaceutical company Repros Therapeutics close over 76% higher by the closing bell, reacting to a press release issued by the company after Wednesday's trading.
http://seekingalpha.com/article/1310281-repros-moves-up-on-phase-iii-data-both-co-endpoints-met?source=feed
http://seekingalpha.com/article/1310281-repros-moves-up-on-phase-iii-data-both-co-endpoints-met?source=feed
No comments:
Post a Comment